High Court Denies Review on Drug Compounding Competition Suit – Bloomberg Law News
Analysis of US Supreme Court’s Decision on Compounded Prescription Drugs Background In July 2023, the US Court of Appeals for the Ninth Circuit ruled in favor of Fagron Compounding LLC, a drugmaker accused of violating state consumer protection laws by selling unapproved compounded prescription drugs. The decision overturned a district court ruling in favor of […] More